Posted at 8th September 2013 by Ryan Luce
written by Michael O’Leary
Metformin may be the aspirin of type 2 diabetes. It just seems as if the benefits of metformin therapy seem to grow the more researchers study it.
A case in point is new study published online last week in the Journal of Clinical Oncology. It showed that men with type 2 diabetes and prostate cancer lived longer and were much less likely to die of prostate cancer when treated with metformin.